Endurance Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-87
Closed -$4K 645
2020
Q4
$4K Hold
87
﹤0.01% 534
2020
Q3
$3K Hold
87
﹤0.01% 543
2020
Q2
$3K Hold
87
﹤0.01% 531
2020
Q1
$2K Hold
87
﹤0.01% 505
2019
Q4
$3K Hold
87
﹤0.01% 477
2019
Q3
$3K Hold
87
﹤0.01% 476
2019
Q2
$4K Hold
87
﹤0.01% 426
2019
Q1
$4K Hold
87
﹤0.01% 428
2018
Q4
$4K Hold
87
﹤0.01% 423
2018
Q3
$6K Hold
87
﹤0.01% 421
2018
Q2
$5K Hold
87
﹤0.01% 436
2018
Q1
$4K Hold
87
﹤0.01% 464
2017
Q4
$4K Hold
87
﹤0.01% 454
2017
Q3
$4K Hold
87
﹤0.01% 444
2017
Q2
$3K Hold
87
﹤0.01% 464
2017
Q1
$3K Hold
87
﹤0.01% 467
2016
Q4
$3K Hold
87
﹤0.01% 450
2016
Q3
$3K Sell
87
-124
-59% -$4.34K ﹤0.01% 444
2016
Q2
$7K Sell
211
-12
-5% -$368 ﹤0.01% 407
2016
Q1
$6 Hold
223
﹤0.01% 424
2015
Q4
$7K Sell
223
-6
-3% -$187 ﹤0.01% 429
2015
Q3
$6K Hold
229
﹤0.01% 439
2015
Q2
$9K Buy
+229
New +$10.3K ﹤0.01% 413

Other funds holding AVNS

Endurance Wealth Management's AVNS Position: Q1 2021 in Review

Endurance Wealth Management sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 87 shares — an estimated $4K sold.

Endurance Wealth Management first reported a position in AVNS in Q2 2015 and held it in 23 quarters. The position peaked at $9K in Q2 2015. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

  • Endurance Wealth Management reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
  • Endurance Wealth Management sold 87 Avanos Medical shares in Q1 2021, an estimated $4K.
  • Endurance Wealth Management first reported a position in Avanos Medical in Q2 2015 and held it in 23 quarters.
  • Endurance Wealth Management's Avanos Medical position peaked at $9K in Q2 2015.
  • 291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on Endurance Wealth Management's 13F filing for Q1 2021, filed 5 May 2021.